AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Solifenacin Succinate in Kenya
7 products registered with PPB — 7 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Solifen 5 mg Tablets Film-Coated Tablet | H2012/CTD378/054/R1 | Getz Pharma (Pvt) Limited | active | 18 May 2031 |
| GOAB 10 Tablet | H2025/CTD11356/20898 | M/s. Hetero Labs Limited | active | 8 Jul 2030 |
| GOAB 5 Tablet | H2025/CTD11354/20890 | M/s. Hetero Labs Limited | active | 8 Jul 2030 |
| BLACIDEC 10 Film-Coated Tablet | H2022/CTD9136/18490 | MSN Laboratories Private Limited | active | 1 Dec 2027 |
| BLACIDEC 5 Tablet | H2022/CTD9294/16550 | MSN LABORATORIES PRIVATE LIMITED | active | 30 Nov 2027 |
| URYSOREN-5mg Tablet | H2022/CTD9180/17601 | Micro Labs Limited | active | 13 Oct 2027 |
| URYSOREN-10 Tablet | H2022/CTD8631/17602 | Micro Labs Limited | active | 13 Oct 2027 |
Solifenacin Succinate — PPB Registration Details
PPB (Kenya) has 7 registered products containing Solifenacin Succinate, of which 7 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Solifenacin Succinate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.